Apnimed to Participate in the 7th Annual Evercore HealthCONx Conference
CAMBRIDGE, Mass., Nov. 21, 2024 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused on discovery, development, and commercialization of first-in-class oral therapies that address the neuromuscular dysfunction of obstructive sleep